Roussakis, C. | IICIMED

Roussakis, C.

Publications

P198

Cancers, 2019, 11, 1094.

Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death.

Iradyan, M. | Iradyan, N. | Hulin, P. | Hambardzumyan, A. | Gyulkhandanyan, A. | Alves de Sousa, R. | Hessani, A. | Roussakis, C. | Bollot, G. | Bauvais, C. | Sakanyan, V. Targeting

doi: 10.3390/cancers11081094

P197

Mar. Drugs 2019, 17, 372.

Steroids from Marine-Derived Fungi: Evaluation of Antiproliferative and Antimicrobial Activities of Eburicol.

Dos Santos Dias, A. C. | Couzinet-Mossion, A. | Ruiz, N. | Lakhdar, F. | Etahiri, S. | Bertrand, S. | Ory, L. | Roussakis, C. | Pouchus, Y.-F. | Nazih, H. | Wielgosz-Collin, G.

doi:10.3390/md17060372

P196

ChemBioChem 2019, 20, 2255-2261.

Rapid synthesis and antiproliferative properties of polyazamacrocycle-based bi- and tetra-gold(I) phosphine dithiocarbamate complexes.

Flores, O. | Velic, D. | Mabrouk, N. | Bettaieb, A. | Tomasoni, C. | Robert, J.-M. | Paul, C. | Goze, C. | Roussakis, C. | Bodio, E.

doi: 10.1002/cbic.201900227

P184

Haspin: a promising target for the design of inhibitors as potent anticancer drugs.

Amoussou, N. G. | Bigot, A. | Roussakis, C. | Robert, J.-M.

doi : 10.1016/j.drudis.2017.10.005

P180

Chem. J. Arm. 2018, 71, 559–570.

Synthesis of furfuryl derivatives of 4-allyl-1-(4-hydroxy-3-nitrobenzyl)-3-[2- (4-alkoxyphenyl)-quinolin-4-yl]-4,5-dihydro-1H-1,2,4-triazole-5-thions and their toxicity in cancer cells.

Iradyan, M. A. | Iradyan, N. S. | Hambardzumyan, A. A. | Minasyan, N. S. | Roussakis, C. | Sakanyan, V. A.

P159

Fitoterapia 2016, 115, 9-14.

Chemical constituents from Cordia alliodora and C. colloccoca (Boraginaceae) and their biological activities.

Fouseki, M. M. | Damianakos, H. | Karikas, G. A. | Roussakis, C. | P Gupta, M. | Chinou, I.

doi: 10.1016/j.fitote.2016.09.004

P155

Anticancer Res. 2016, 36, 1621-1630.

Discovery of (imidazo[1,2-a]pyrazin-6-yl)ureas as antiproliferative agents targeting P53 in non-small cell lung cancer cell lines.

Bazin, M.-A. | Rousseau, B. | Marhadour, S. | Tomasoni, C. | Evenou, P. | Piessard, S. | Vaisberg, A. J. | Ruchaud, S. | Bach, S. | Roussakis, C. | Marchand, P.

P154

Sci. Rep. 2016, 6, 21088;

Activation of EGFR by small compounds through coupling the generation of hydrogen peroxide to stable dimerization of Cu/Zn SOD1.

Sakanyan, V. | Hulin, P. | Alves de Sousa, R. | Silva, V. A. | Hambardzumyan, A. | Nedellec, S. | Tomasoni, C. | Logé, C. | Pineau, C. | Roussakis, C. | Fleury F. | Artaud, I.

doi:10.1038/srep21088.

P138

Sci. Rep. 2015, 5:10356

 TP53 transcription factor to NEDD9/HEF1/Cas-L gene: potential targets in Non Small Cell Lung Cancer treatment.

Rousseau, B. | Jacquot, C. | Le Palabe, J. | Malleter, M. | Tomasoni, C. | Boutard, T. | Sakanyan, V. | Roussakis, C.

doi: 10.1038/srep10356

P133

Anticancer Res. 2014, 34, 4797-4806. 

Cucurbitacin-D-induced CDK1 mRNA Up-regulation Causes Proliferation Arrest of a Non-small Cell Lung Carcinoma Cell Line (NSCLC-N6).

Jacquot, C | Rousseau, B | Carbonnelle, D | Chinou, I | Malleter, M | Tomasoni, C | Roussakis, C.

P126

Sci. Rep. 2014, 4:3977.

Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells.

Sakanyan, V. | Angelini, M. | Le Béchec, M. | Lecocq, M.-F. | Benaiteau, F. | Rousseau, B. | Gyulkhandanyan, A. | Gyulkhandanyan, L. | Logé, C. | Reiter, E. | Roussakis, C. | Fleury, F.

doi: 10.1038/srep03977.

P121

Eur. J. Med. Chem., 2013, 69, 823-832.

Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.

Bazin, M.-A. | Bodero, L. | Tomasoni, C. | Rousseau, B. | Roussakis, C. | Marchand, P.

P111

J. Ocul. Pharmacol. Ther. 2012, 28, 299-306. 

Study of antiproliferative effects of synthetic substances against lens epithelial cell line (SRA01/04).

Malleter, M. | Jacquot, C. | Rousseau, B. | Tomasoni, C. | Ducourneau, D. | Tourette, P. | Pineau, A. | Roussakis, C.

P110

Gene, 2012, 506, 355-9.

miRNAs, a potential target in the treatment of Non-Small Cell Lung Carcinomas.

Malleter, M. | Jacquot, C. | Rousseau, B. | Tomasoni, C. | Jugé, M. | Pineau, A. | Sakanian, V. | Roussakis, C.

Autres publications scientifiques

Brevets

Thèse